- Home
- / Invent Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Invent Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
KČ70.1 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CZK | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 26.4M | 41.8M | 70.1M |
| Cost of goods sold | 13.6M | 25.5M | 42.0M |
| Gross profit | 12.8M | 16.3M | 28.1M |
| Gross profit margin, % | 48.4% | 39.0% | 40.1% |
| General and administrative expense | 11.2M | 14.3M | 19.4M |
| Operating expense total | 11.6M | 14.8M | 23.0M |
| EBIT | 6.7M | 4.5M | 6.3M |
| EBIT margin, % | 25.4% | 10.8% | 8.9% |
| Interest income | 79.0K | 189.0K | 1.2M |
| Interest expense | 1.6M | ||
| Pre tax profit | 6.6M | 3.1M | 7.6M |
| Income tax expense | 728.0K | 502.0K | 1.2M |
| Net Income | 5.9M | 2.6M | 6.3M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |